Bio­gen un­veils first da­ta from Spin­raza fol­low-on, plans late-stage pro­gram

Bio­gen shared that its next-gen­er­a­tion spinal mus­cu­lar at­ro­phy RNA drug im­proved mea­sures of neu­rode­gen­er­a­tion and mo­tor func­tion in an ini­tial cut of da­ta, and the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER